Country: Malta
Language: English
Source: Medicines Authority
BECLOMETASONE DIPROPIONATE
Generics UK Limited Station Close, Potters Bar, Herts, EN6 1TL, United Kingdom
R01AD01
BECLOMETASONE DIPROPIONATE 50 µg
NASAL SPRAY, SOLUTION
BECLOMETASONE DIPROPIONATE 50 µg
POM
NASAL PREPARATIONS
Withdrawn
2006-09-28
COLOURS: Black PL: 4569/0326 APPROVED TO PRINT: Marketing Registration Production Customer Quality Assurance Generics [UK] Limited, Design Department Albany Gate, Darkes Lane, Potters Bar, Herts, EN6 1AG CUSTOMER: ANY OLS DESIGNER: Maria Toumazou PRODUCT: Beclometasone Nasal Spray 50 mcg x 200's POM ITEM CODE: (BU-I) 302194 PHARMACODE: Pacific's DIMENSIONS: 150 X 140 mm PROOF NO & DATE: 3 21/06/04 REVISION: BAN's to rINN's. Packed @ Pacific. To run in parallel with Inyx packing. Further text changes from MDSG. SUPERSEDES: (BG-I) 301890 ARTWORK FOR SUBMISSION KEEP ALL MEDICATION OUT OF THE REACH AND SIGHT OF CHILDREN. BEFORE YOU USE YOUR MEDICINE PLEASE READ THIS LEAFLET CAREFULLY. This leaflet contains a summary of the information about your medicine, Beclometasone Dipropionate Aqueous Nasal Spray 50 micrograms per spray. YOUR MEDICINE Your medicine is in the form of a nasal spray. Each dose contains 50 micrograms of the active ingredient Beclometasone Dipropionate. The nasal spray also contains Dextrose, Polysorbate 80, Microcrystalline Cellulose, Sodium Carboxymethyl Cellulose, Benzalkonium Chloride, Phenylethanol and Purified Water. The active ingredient in this medicine is Beclometasone Dipropionate. This is the new name for Beclomethasone Dipropionate. The ingredient itself has not changed. This medicine is available in a brown glass bottle fitted with a white nozzle and provides you with approximately 200 doses of drug. HOW DOES YOUR MEDICINE WORK ? Beclometasone Dipropionate is a steroid. It acts by reducing the inflammation in the lining of your nose which may be the cause of your sneezing, itchy, blocked or runny nose. Product Licence Holder and Manufacturer: Generics [UK] Limited, Station Close, Potters Bar, Hertfords Read the complete document
Page 1 of 6 SUMMARY OF PRODUCT CHARACTERISTICS PRODUCT SUMMARY 1. TRADE NAME OF THE MEDICINAL PRODUCT Category POM Beclometasone Dipropionate Aqueous Nasal Spray, 50 micrograms per spray. 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each spray contains: Beclometasone Dipropionate Ph. Eur., 50 micrograms 3. PHARMACEUTICAL FORM Mechanical driven (atomising) spray for nasal use. CLINICAL PARTICULARS 4.1. THERAPEUTIC INDICATIONS Category POM Beclometasone Dipropionate Aqueous Nasal Spray is indicated for the treatment and prevention of seasonal and perennial allergic rhinitis; hayfever and vasomotor rhinitis. The drug has a potent anti-inflammatory effect within the respiratory tract at doses which are not systemically active. 4.2. POSOLOGY AND METHOD OF ADMINISTRATION Category POM Beclometasone Dipropionate Aqueous Nasal Spray for intranasal administration only. Adults and children: There is insufficient clinical data at present to support the recommended use of this product in children under the age of six. A dose range of 200 to 400 µg per day is recommended. The recommended dosage for adults and children is two sprays into each nostril twice daily. Once control of symptoms has been achieved a single spray into each nostril twice a day may be preferred. However, the minimum dose should be used at which effective control of symptoms is maintained. The total daily dose should not normally exceed eight sprays (400 micrograms/day). Page 2 of 6 For full therapeutic benefit regular use is essential. Furthermore, it should be explained to the patient that maximum relief may not be obtained with the first few doses and that patients co-operation to comply with the regular dosage schedule should be sought. 4.3. CONTRA-INDICATIONS Beclometasone Dipropionate Aqueous Nasal Spray is_ _contra-indicated in patients with a histo Read the complete document